vs

Side-by-side financial comparison of EXTREME NETWORKS INC (EXTR) and AMICUS THERAPEUTICS, INC. (FOLD). Click either name above to swap in a different company.

EXTREME NETWORKS INC is the larger business by last-quarter revenue ($316.9M vs $185.2M, roughly 1.7× AMICUS THERAPEUTICS, INC.). EXTREME NETWORKS INC runs the higher net margin — 3.3% vs 0.9%, a 2.4% gap on every dollar of revenue. On growth, AMICUS THERAPEUTICS, INC. posted the faster year-over-year revenue change (23.7% vs 11.4%). AMICUS THERAPEUTICS, INC. produced more free cash flow last quarter ($16.0M vs $7.8M). Over the past eight quarters, AMICUS THERAPEUTICS, INC.'s revenue compounded faster (29.5% CAGR vs 11.1%).

Extreme Networks, Inc. is an American networking company based in Morrisville, North Carolina. Extreme Networks designs, develops, and manufactures wired and wireless network infrastructure equipment and develops the software for network management, policy, analytics, security and access controls.

Amicus Therapeutics, Inc. is a public American biopharmaceutical company based in Philadelphia, Pennsylvania. The company went public in 2007 under the Nasdaq trading symbol FOLD. This followed a 2006 planned offering and subsequent withdrawal, which would have established the trading symbol as AMTX Prior to their IPO, Amicus was funded by a variety of venture capital firms including Radius Ventures, Canaan Partners and New Enterprise Associates.

EXTR vs FOLD — Head-to-Head

Bigger by revenue
EXTR
EXTR
1.7× larger
EXTR
$316.9M
$185.2M
FOLD
Growing faster (revenue YoY)
FOLD
FOLD
+12.3% gap
FOLD
23.7%
11.4%
EXTR
Higher net margin
EXTR
EXTR
2.4% more per $
EXTR
3.3%
0.9%
FOLD
More free cash flow
FOLD
FOLD
$8.2M more FCF
FOLD
$16.0M
$7.8M
EXTR
Faster 2-yr revenue CAGR
FOLD
FOLD
Annualised
FOLD
29.5%
11.1%
EXTR

Income Statement — Q4 FY2026 vs Q4 FY2025

Metric
EXTR
EXTR
FOLD
FOLD
Revenue
$316.9M
$185.2M
Net Profit
$10.6M
$1.7M
Gross Margin
61.7%
85.7%
Operating Margin
5.5%
8.6%
Net Margin
3.3%
0.9%
Revenue YoY
11.4%
23.7%
Net Profit YoY
202.9%
-88.5%
EPS (diluted)
$0.08
$0.00

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
EXTR
EXTR
FOLD
FOLD
Q2 26
$316.9M
Q4 25
$317.9M
$185.2M
Q3 25
$310.2M
$169.1M
Q2 25
$307.0M
$154.7M
Q1 25
$284.5M
$125.2M
Q4 24
$279.4M
$149.7M
Q3 24
$269.2M
$141.5M
Q2 24
$256.7M
$126.7M
Net Profit
EXTR
EXTR
FOLD
FOLD
Q2 26
$10.6M
Q4 25
$7.9M
$1.7M
Q3 25
$5.6M
$17.3M
Q2 25
$-7.8M
$-24.4M
Q1 25
$3.5M
$-21.7M
Q4 24
$7.4M
$14.7M
Q3 24
$-10.5M
$-6.7M
Q2 24
$-54.2M
$-15.7M
Gross Margin
EXTR
EXTR
FOLD
FOLD
Q2 26
61.7%
Q4 25
61.4%
85.7%
Q3 25
60.6%
88.5%
Q2 25
61.6%
90.2%
Q1 25
61.7%
90.7%
Q4 24
62.7%
90.1%
Q3 24
63.0%
90.6%
Q2 24
44.7%
91.1%
Operating Margin
EXTR
EXTR
FOLD
FOLD
Q2 26
5.5%
Q4 25
4.1%
8.6%
Q3 25
3.6%
20.3%
Q2 25
-0.4%
-6.1%
Q1 25
3.6%
-6.3%
Q4 24
4.5%
10.7%
Q3 24
-1.8%
15.3%
Q2 24
-19.1%
11.8%
Net Margin
EXTR
EXTR
FOLD
FOLD
Q2 26
3.3%
Q4 25
2.5%
0.9%
Q3 25
1.8%
10.2%
Q2 25
-2.5%
-15.8%
Q1 25
1.2%
-17.3%
Q4 24
2.6%
9.8%
Q3 24
-3.9%
-4.8%
Q2 24
-21.1%
-12.4%
EPS (diluted)
EXTR
EXTR
FOLD
FOLD
Q2 26
$0.08
Q4 25
$0.06
$0.00
Q3 25
$0.04
$0.06
Q2 25
$-0.07
$-0.08
Q1 25
$0.03
$-0.07
Q4 24
$0.06
$0.05
Q3 24
$-0.08
$-0.02
Q2 24
$-0.40
$-0.05

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
EXTR
EXTR
FOLD
FOLD
Cash + ST InvestmentsLiquidity on hand
$210.1M
$293.5M
Total DebtLower is stronger
$392.7M
Stockholders' EquityBook value
$274.2M
Total Assets
$1.2B
$949.9M
Debt / EquityLower = less leverage
1.43×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
EXTR
EXTR
FOLD
FOLD
Q2 26
$210.1M
Q4 25
$219.8M
$293.5M
Q3 25
$209.0M
$263.8M
Q2 25
$231.7M
$231.0M
Q1 25
$185.5M
$250.6M
Q4 24
$170.3M
$249.9M
Q3 24
$159.5M
$249.8M
Q2 24
$156.7M
$260.1M
Total Debt
EXTR
EXTR
FOLD
FOLD
Q2 26
Q4 25
$392.7M
Q3 25
$392.0M
Q2 25
$180.0M
$391.3M
Q1 25
$390.7M
Q4 24
$390.1M
Q3 24
$389.5M
Q2 24
$190.0M
$388.9M
Stockholders' Equity
EXTR
EXTR
FOLD
FOLD
Q2 26
Q4 25
$95.9M
$274.2M
Q3 25
$68.6M
$230.4M
Q2 25
$65.6M
$204.3M
Q1 25
$71.7M
$193.6M
Q4 24
$51.2M
$194.0M
Q3 24
$32.7M
$178.8M
Q2 24
$25.3M
$132.5M
Total Assets
EXTR
EXTR
FOLD
FOLD
Q2 26
$1.2B
Q4 25
$1.2B
$949.9M
Q3 25
$1.2B
$868.8M
Q2 25
$1.2B
$815.3M
Q1 25
$1.1B
$789.8M
Q4 24
$1.1B
$785.0M
Q3 24
$1.1B
$786.6M
Q2 24
$1.0B
$749.5M
Debt / Equity
EXTR
EXTR
FOLD
FOLD
Q2 26
Q4 25
1.43×
Q3 25
1.70×
Q2 25
2.74×
1.92×
Q1 25
2.02×
Q4 24
2.01×
Q3 24
2.18×
Q2 24
7.52×
2.93×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
EXTR
EXTR
FOLD
FOLD
Operating Cash FlowLast quarter
$50.3M
$16.3M
Free Cash FlowOCF − Capex
$7.8M
$16.0M
FCF MarginFCF / Revenue
2.5%
8.6%
Capex IntensityCapex / Revenue
0.2%
Cash ConversionOCF / Net Profit
4.75×
9.62×
TTM Free Cash FlowTrailing 4 quarters
$105.3M
$29.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
EXTR
EXTR
FOLD
FOLD
Q2 26
$50.3M
Q4 25
$50.1M
$16.3M
Q3 25
$-14.0M
$35.7M
Q2 25
$81.9M
$-26.5M
Q1 25
$30.0M
$7.8M
Q4 24
$21.5M
$-3.9M
Q3 24
$18.6M
$-23.0M
Q2 24
$15.5M
$22.7M
Free Cash Flow
EXTR
EXTR
FOLD
FOLD
Q2 26
$7.8M
Q4 25
$43.0M
$16.0M
Q3 25
$-20.9M
$35.3M
Q2 25
$75.3M
$-28.9M
Q1 25
$24.2M
$7.5M
Q4 24
$16.1M
$-4.2M
Q3 24
$11.7M
$-23.3M
Q2 24
$11.0M
$21.6M
FCF Margin
EXTR
EXTR
FOLD
FOLD
Q2 26
2.5%
Q4 25
13.5%
8.6%
Q3 25
-6.7%
20.9%
Q2 25
24.5%
-18.7%
Q1 25
8.5%
6.0%
Q4 24
5.8%
-2.8%
Q3 24
4.3%
-16.5%
Q2 24
4.3%
17.0%
Capex Intensity
EXTR
EXTR
FOLD
FOLD
Q2 26
Q4 25
2.2%
0.2%
Q3 25
2.2%
0.2%
Q2 25
2.2%
1.6%
Q1 25
2.0%
0.2%
Q4 24
1.9%
0.2%
Q3 24
2.6%
0.3%
Q2 24
1.7%
0.9%
Cash Conversion
EXTR
EXTR
FOLD
FOLD
Q2 26
4.75×
Q4 25
6.37×
9.62×
Q3 25
-2.49×
2.06×
Q2 25
Q1 25
8.67×
Q4 24
2.92×
-0.27×
Q3 24
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

EXTR
EXTR

Product$199.4M63%
Subscription and support$117.5M37%

FOLD
FOLD

Other$105.8M57%
Galafold$64.8M35%
Pombiliti Opfolda$14.6M8%

Related Comparisons